Welcome to a new class of drug delivery systems for ODTs: Galvita's TIP-Technology!
Galvita’s revolutionary, patented, and repeatedly clinically tested technology enables the production of micro capsules (Templated Inverted Particles / TIP) that can be loaded with many different active ingredients and easily compressed to tablets with excellent mechanical strength.
The unique properties of TIP-based tablets offer many benefits over other oral dosage forms, such as ultra-rapid disintegration (5-10 sec), fast onset of action (reduced first-pass effect), water-free ingestion (no swallowing), smaller tablet sizes, taste masking and a neutral product composition (100% pure calcium phosphate TIP, compendial and inorganic material).
Galvita offers licensing of the patented technology, value adding services in formulation development such as feasibility/early formulation, R&D and scale-up support, as well as support in setting up and conducting clinical testing and studies .
Company Details
- Employees
- 16
- Founded
- 2020
- Address
- Mattenstrasse 22, Basel,4058,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://galvita.com/
- HQ
- Basel
Galvita Ag Questions
Galvita Ag's website is https://galvita.com/
Galvita Ag's LinkedIn profile is https://ch.linkedin.com/company/galvita
Galvita Ag has
16 employees.
View email and phone details for 16
employees at Galvita Ag.
Galvita Ag's industry is
Biotechnology Research
Galvita Ag's top competitors are
Lactalis Ingredients Pharma,
Hänseler Swiss Pharma,
Obaris,
Beyond Diagnostics,
Insybio,
Pharmatrans Sanaq Ag,
Axom Solutions,
Hypha Discovery Ltd,
Cocoon Bioscience,
Oryl Photonics.
Galvita Ag's categories are Biotechnology Research
Galvita Ag's founding year is 2020
